Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000
EPIDEMIOLOGICAL AND molecular evidence suggests that there are multiple etiologies for Alzheimer disease (AD). Studies of the incidence and patterns of transmission in families demonstrate that relatives of affected individuals have an increased risk of developing AD compared with members of the general population.1 With the exception of rare (probably <1%) cases harboring pathogenic mutations in the amyloid precursor protein or presenilin genes, susceptibility is governed by a complex interaction of genes and environmental factors. The most potent factor identified to date is the ϵ4 allele of apolipoprotein E conferring a relative risk of between 2.7 and 3.2 in persons having a single copy and between 12.5 and 14.9 in those homozygous for this factor.2 Notably, these conclusions were drawn from studies of largely white populations.
Farrer LA. Familial Risk for Alzheimer Disease in Ethnic MinoritiesNondiscriminating Genes. Arch Neurol. 2000;57(1):28–29. doi:10.1001/archneur.57.1.28
Customize your JAMA Network experience by selecting one or more topics from the list below.